Recent news highlights Acadia Healthcare’s third quarter 2026 revenue of $895.3 million and raised full year 2026 financial guidance. The company surpassed Q3 earnings and revenue expectations, reflecting operational strength.

• Acadia Healthcare reported third quarter 2026 revenue of $895.3 million and raised full year 2026 financial guidance [N1].
• The company surpassed Q3 earnings and revenue estimates as reported on November 4, 2026 [N2].
• Acadia’s growth strategy includes expansions, joint ventures, de novo facilities, and acquisitions to serve high-acuity behavioral health patients [S1].

Acadia’s diversified growth strategy through expansions, joint ventures, and acquisitions supports its position as a leading behavioral healthcare provider. The company’s ability to raise financial guidance and report strong quarterly revenue and earnings reflects operational execution. Its scale and geographic reach provide competitive advantages in a fragmented industry. Continued facility additions and partnerships with health systems may enhance service offerings and patient access.

Risks include regulatory and reimbursement uncertainties that could impact revenue and profitability. Staffing shortages and labor cost pressures may affect operational efficiency. Integration challenges from acquisitions and joint ventures could limit realization of synergies. The company’s indebtedness and reliance on capital markets pose financial risks. Additionally, cybersecurity threats and compliance with privacy laws present ongoing operational risks.

Acadia Healthcare’s moat derives from its scale as a leading pure-play behavioral healthcare provider with a broad geographic footprint and diversified facility types. Its growth strategy leverages multiple pathways including acquisitions, joint ventures with established health systems, and de novo developments, which provide access to new markets and patient populations. The company’s extensive network and specialized focus on high-acuity behavioral health patients create barriers to entry for competitors. Additionally, its relationships with referral sources and managed care organizations support patient volume and revenue stability.

• Regulatory and Legal Risks: The company faces risks from investigations, regulatory actions, and compliance with healthcare laws which could impact operations and financial results [S1].
• Staffing and Labor Challenges: Competition for qualified healthcare personnel and labor shortages may increase costs and affect service delivery [S1].
• Reimbursement and Payment Risks: Changes in Medicare, Medicaid, and third-party payor payment rates and practices could adversely affect revenue [S1].
• Integration and Operational Risks: Difficulties in integrating acquisitions and joint ventures may limit expected benefits and synergies [S1].
• Financial and Capital Risks: The company’s indebtedness and ability to access capital on acceptable terms pose risks to liquidity and financial flexibility [S1,S2].
• Cybersecurity and Data Privacy: Risks of cybersecurity incidents and compliance with patient information privacy laws could disrupt operations and result in penalties [S1].
• Market and Economic Risks: Macroeconomic conditions, inflation, and competitive pressures may impact patient volumes and operating results [S1].

• Acadia Healthcare Company, Inc. is a publicly traded pure-play provider of behavioral healthcare services in the U.S. [S1].
• As of December 31, 2025, Acadia operated 277 behavioral healthcare facilities with over 12,500 beds across 40 states and Puerto Rico [S1].
• The company’s business strategy focuses on serving high-acuity and complex needs patient populations through expansions, joint ventures, de novo facilities, acquisitions, and continuum of care expansion [S1].
• Acadia’s headquarters is located in Franklin, Tennessee, leasing approximately 63,000 square feet of office space [S1].
• The company has a share repurchase program authorized for up to $300 million, with $250 million remaining as of December 31, 2025 [S1].
• Acadia has not declared or paid dividends and intends to retain earnings to fund growth and repay debt [S1].
• The company acquired Turning Point, a 76-bed specialty provider of substance use disorder and mental health treatment services in Salt Lake City, Utah, in February 2024 [S1].
• For the quarter ended September 30, 2026, Acadia reported cash and equivalents of $163.3 million, current assets of $881.3 million, current liabilities of $552.0 million, a current ratio of 1.6, and a cash ratio of 0.3 [S2].
• Net income for Q3 2026 was $34.5 million with basic and diluted EPS of $0.38 per share [S2].
• Recent news reports indicate Acadia Healthcare reported third quarter 2026 revenue of $895.3 million and raised full year 2026 financial guidance [N1].
• Acadia surpassed Q3 earnings and revenue expectations as reported in recent news [N2].
• The company’s growth pathways include facility expansions, joint ventures with health systems, de novo facilities, and acquisitions [S1].
• Risk factors disclosed include regulatory compliance, staffing challenges, reimbursement changes, integration risks, cybersecurity, and macroeconomic conditions [S1].